NovaBay Says Its Avenova Cuts Bacteria On Ocular Skin Surface By Over 90% By: Benzinga via Benzinga May 03, 2016 at 08:43 AM EDT NovaBay Pharmaceuticals, Inc. (NYSE: NBY) revealed the presentation of clinical data demonstrating that its Avenova reduced the ... Read More >> Related Stocks: Novabay Pharmaceuticals